|
C14ORF4 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.420430E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.412400E-01 |
| Normal-vs-Stage2 |
2.445800E-02 |
| Normal-vs-Stage3 |
3.181800E-01 |
| Normal-vs-Stage4 |
1.734220E-01 |
| Stage1-vs-Stage2 |
9.566400E-02 |
| Stage1-vs-Stage3 |
9.103800E-01 |
| Stage1-vs-Stage4 |
6.900200E-01 |
| Stage2-vs-Stage3 |
1.050020E-01 |
| Stage2-vs-Stage4 |
2.298400E-01 |
| Stage3-vs-Stage4 |
6.521400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.459200E-01 |
| Normal-vs-AfricanAmerican |
5.261900E-02 |
| Normal-vs-Asian |
2.557200E-01 |
| Caucasian-vs-AfricanAmerican |
1.608810E-01 |
| Caucasian-vs-Asian |
8.063000E-01 |
| AfricanAmerican-vs-Asian |
3.013400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.953980E-01 |
| Normal-vs-Female |
1.452200E-01 |
| Male-vs-Female |
9.115200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.879000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.380390E-01 |
| Normal-vs-Age(61-80Yrs) |
8.407900E-02 |
| Normal-vs-Age(81-100Yrs) |
3.193200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.142600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.787980E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.745200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.340200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.470000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.911600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.147800E-02 |
| Classical-VS-Follicular |
6.247400E-01 |
| Classical-VS-Other |
1.074800E-01 |
| Classical-VS-Normal |
4.589500E-02 |
| Tall-VS-Follicular |
1.776390E-01 |
| Tall-VS-Other |
3.850600E-01 |
| Tall-VS-Normal |
8.896000E-01 |
| Follicular-VS-Other |
2.848600E-01 |
| Follicular-VS-Normal |
2.330600E-01 |
| Other-VS-Normal |
4.209200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.676380E-01 |
| Normal-vs-N1 |
9.250200E-01 |
| N0-vs-N1 |
2.102600E-01 |
|
|
